Oral Molnupiravir to Treat Mild-to-Moderate Covid-19

Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19 It is used by adults 18 years of age and older who have

we evaluated the safety and optimal dose of molnupiravir in participants with early symptomat- ic infection Methods: We undertook a dose

molnupiravir dose Double doses should not be taken to compensate for missed doses DOSE To date, no drug interactions with molnupiravir have been identified The

molnupiravir ราคา Do not take a double dose to make up for a missed dose • If you are not sure what to do, call your doctor or pharmacist Do not stop taking Lagevrio Do not